Bokus
Harry Yang - Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing, Häftad

Häftad, Engelska, 2020

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

Av Harry Yang

Del i serien Chapman & Hall/CRC Biostatistics Series

837 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.
Produktinformation
Utforska kategorier
Mer om författaren

Harry Yang, Ph.D., is senior director and head of the Non-Clinical Biostatistics Group at MedImmune, the global biologics arm of AstraZeneca headquartered in Gaithersburg, Maryland.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.